Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dexamethasone 500micrograms/5ml oral liquid
0603020G0AAA7A7
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 14 |
|
Diavic 6mg/ml solution for injection 3ml pre-filled pens
0601023ABBFAAAA
|
Diavic | Liraglutide | Endocrine System | 14 |
|
GSF-Syrup oral gel 18g sachets peppermint
0601040I0BDAAAG
|
GSF-Syrup | Glucose | Endocrine System | 14 |
|
Nateglinide 120mg tablets
0601023U0AAABAB
|
Nateglinide | Nateglinide | Endocrine System | 14 |
|
palmdoc iCare Advanced Solo testing strips
0601060D0DLAAA0
|
Palmdoc iCare Advanced Solo (Reagent) | Glucose blood testing reagents | Endocrine System | 14 |
|
Somatropin (rbe) 1mg inj pre-filled disposable devices
0605010S0AAAHAH
|
Somatropin | Somatropin | Endocrine System | 14 |
|
Vencamil 50microgram tablets
0602010V0BKACBX
|
Vencamil | Levothyroxine sodium | Endocrine System | 14 |
|
Carbimazole 5mg/5ml oral liquid
0602020D0AAAKAK
|
Carbimazole | Carbimazole | Endocrine System | 13 |
|
Diazoxide 25mg capsules
0601040E0AAAGAG
|
Diazoxide (Systemic) | Diazoxide | Endocrine System | 13 |
|
Glibenclamide 2.5mg tablets
0601021H0AAAAAA
|
Glibenclamide | Glibenclamide | Endocrine System | 13 |
|
Lyxumia 10micrograms/0.2ml inj 3ml pre-filled pens
0601023AIBBABAB
|
Lyxumia | Lixisenatide | Endocrine System | 13 |
|
Sitagliptin 125mg/5ml oral solution sugar free
0601023X0AAAGAG
|
Sitagliptin | Sitagliptin | Endocrine System | 13 |
|
DDAVP 4micrograms/1ml solution for injection ampoules
0605020E0BBABAA
|
DDAVP | Desmopressin acetate | Endocrine System | 12 |
|
Ethinylestradiol 2microgram tablets
0604011D0AAALAL
|
Ethinylestradiol (Systemic) | Ethinylestradiol | Endocrine System | 12 |
|
Iasibon 50mg tablets
0606020W0BDAAAB
|
Iasibon | Ibandronic acid | Endocrine System | 12 |
|
Insulin isoph biphas hum 30/70 100u/ml inj 3ml pf dispos dev
0601012D0AABZBZ
|
Biphasic isophane insulin | Biphasic isophane insulin | Endocrine System | 12 |
|
Levothyroxine sodium 25micrograms/5ml oral liquid
0602010V0AACZCZ
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 12 |
|
Metopirone 250mg capsules
0607030M0BBAAAA
|
Metopirone | Metyrapone | Endocrine System | 12 |
|
Rudimet 1000mg prolonged-release tablets
0601022B0BUABAV
|
Rudimet | Metformin hydrochloride | Endocrine System | 12 |
|
Tolvaptan 15mg tablets
0605020Y0AAAAAA
|
Tolvaptan | Tolvaptan | Endocrine System | 12 |
|
Diazoxide 250mg/5ml oral solution
0601040E0AAAYAY
|
Diazoxide (Systemic) | Diazoxide | Endocrine System | 11 |
|
Ibandronic acid 3mg/3ml inj pre-filled syringes
0606020W0AAAEAE
|
Ibandronic acid | Ibandronic acid | Endocrine System | 11 |
|
Ins glargine 100u/ml / Lixis 50mcg/ml inj 3ml pf dispos dev
0601012ABAAABAB
|
Insulin glargine/lixisenatide | Insulin glargine/lixisenatide | Endocrine System | 11 |
|
Insulin lispro biphasic 25/75 100units/ml inj 3ml cartridges
0601012F0AAABAB
|
Insulin Lispro biphasic | Biphasic insulin lispro | Endocrine System | 11 |
|
Jesacrin 500mg modified-release tablets
0601022B0BTACAS
|
Jesacrin | Metformin hydrochloride | Endocrine System | 11 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.